PLUS THERAPEUTICS, INC. — Director's Dealing 2010

Feb 9, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-02-05

Reporting Person: Saad Mark E (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-05	Employee Stock Option (Right to Buy)	$6.71	A	100000	Acquired	2020-02-05	Common Stock (100000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	76500	Direct

Footnotes

F1: The Employee Stock Options vest 1/48th each month from the date of grant.